West Oak Capital, LLC Illumina, Inc. Transaction History

West Oak Capital, LLC

$5.38 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 05, 2023	SELL	$128.91 - $192.44 $78,635 - $117,388	-610 Reduced 43.88%	780 $107,000
Q2 2023 Jul 19, 2023	SELL	$183.43 - $232.67 $8,254 - $10,470	-45 Reduced 3.14%	1,390 $260,000
Q1 2023 Apr 21, 2023	SELL	$193.75 - $232.55 $74,012 - $88,834	-382 Reduced 21.02%	1,435 $333,000
Q4 2022 Jan 05, 2023	SELL	$187.24 - $242.74 $187,801 - $243,468	-1,003 Reduced 35.57%	1,817 $367,000
Q3 2022 Oct 28, 2022	SELL	$177.23 - $227.44 $95,704 - $122,817	-540 Reduced 16.07%	2,820 $538,000
Q2 2022 Jul 11, 2022	BUY	$181.58 - $368.0 $78,079 - $158,240	430 Added 14.68%	3,360 $619,000
Q1 2022 Apr 20, 2022	SELL	$303.87 - $423.8 $6,077 - $8,476	-20 Reduced 0.68%	2,930 $1.02 Million
Q4 2021 Jan 12, 2022	SELL	$347.28 - $421.83 $13,891 - $16,873	-40 Reduced 1.34%	2,950 $1.12 Million
Q3 2021 Oct 07, 2021	SELL	$405.61 - $524.84 $64,086 - $82,924	-158 Reduced 5.02%	2,990 $1.21 Million
Q2 2021 Jul 20, 2021	BUY	$372.84 - $481.5 $102,531 - $132,412	275 Added 9.57%	3,148 $1.49 Million
Q1 2021 Apr 13, 2021	BUY	$361.28 - $504.76 $12,644 - $17,666	35 Added 1.23%	2,873 $1.1 Million
Q4 2020 Jan 08, 2021	SELL	$292.7 - $370.96 $10,829 - $13,725	-37 Reduced 1.29%	2,838 $1.05 Million
Q3 2020 Oct 09, 2020	SELL	$268.51 - $400.74 $14,768 - $22,040	-55 Reduced 1.88%	2,875 $889,000
Q2 2020 Jul 06, 2020	BUY	$256.46 - $373.01 $15,387 - $22,380	60 Added 2.09%	2,930 $1.09 Million
Q1 2020 Apr 07, 2020	BUY	$209.2 - $335.53 $39,748 - $63,750	190 Added 7.09%	2,870 $784,000
Q4 2019 Jan 09, 2020	BUY	$288.29 - $335.49 $772,617 - $899,113	2,680 New	2,680 $889,000

Others Institutions Holding ILMN

# of Institutions

900

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $20.6B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Oak Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Oak Capital, LLC with notifications on news.

Account